feed,title,long_url,short_url
Benzinga,Seagen's Tucatinib/Trastuzumab Combo Shows Encouraging Antitumor Activity In Pretreated Colorectal Cancer Patients,https://benzinga.com/general/biotech/22/07/27949222/seagens-tucatinibtrastuzumab-combo-shows-encouraging-antitumor-activity-in-pretreated-colorectal-,https://bit.ly/3yJ8d3p
Benzinga,AstraZeneca Strengthens Its Hematological Cancer Pipeline With TeneoTwo Acquisition,https://benzinga.com/general/biotech/22/07/27948730/astrazeneca-strengthens-its-hematological-cancer-pipeline-with-teneotwo-acquisition,https://bit.ly/3yJ8djV
